Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9P2R3
UPID:
ANFY1_HUMAN
Alternative names:
Ankyrin repeat and FYVE domain-containing protein 1; Ankyrin repeats hooked to a zinc finger motif
Alternative UPACC:
Q9P2R3; A8KA65; Q5RKV4; Q9ULG5
Background:
Rabankyrin-5, known for its alternative names Ankyrin repeat and FYVE domain-containing protein 1 and Ankyrin repeats hooked to a zinc finger motif, plays a pivotal role in cellular processes. It acts as an effector of Rab5, binding to phosphatidylinositol 3-phosphate (PI(3)P) and is crucial in early endosome fusion, macropinocytosis, and the trafficking of tyrosine kinase receptors like PDGFRB. Its involvement extends to regulating the retromer complex's subcellular localization, impacting endosome-to-Golgi transport.
Therapeutic significance:
Understanding the role of Rabankyrin-5 could open doors to potential therapeutic strategies.